|
NKAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.429000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.544980E-01 |
| Normal-vs-Stage2 |
7.523200E-01 |
| Normal-vs-Stage3 |
2.243800E-01 |
| Normal-vs-Stage4 |
1.695850E-01 |
| Stage1-vs-Stage2 |
1.989780E-01 |
| Stage1-vs-Stage3 |
9.615000E-03 |
| Stage1-vs-Stage4 |
6.022200E-01 |
| Stage2-vs-Stage3 |
5.428200E-01 |
| Stage2-vs-Stage4 |
1.601240E-01 |
| Stage3-vs-Stage4 |
2.985900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.868800E-01 |
| Normal-vs-AfricanAmerican |
2.322800E-01 |
| Normal-vs-Asian |
3.693800E-01 |
| Caucasian-vs-AfricanAmerican |
3.556000E-01 |
| Caucasian-vs-Asian |
6.565600E-01 |
| AfricanAmerican-vs-Asian |
9.373800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.522800E-01 |
| Normal-vs-Female |
2.842000E-01 |
| Male-vs-Female |
4.480000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.497000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.229600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.732400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.614000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.938000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.873000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.362800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.619400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.970000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.332600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.957300E-04 |
| Normal-vs-Grade 2 |
4.705900E-02 |
| Normal-vs-Grade 3 |
2.974200E-01 |
| Normal-vs-Grade 4 |
9.612200E-01 |
| Grade 1-vs-Grade 2 |
2.059900E-02 |
| Grade 1-vs-Grade 3 |
9.361900E-04 |
| Grade 1-vs-Grade 4 |
4.536000E-03 |
| Grade 2-vs-Grade 3 |
9.443100E-04 |
| Grade 2-vs-Grade 4 |
1.974600E-01 |
| Grade 3-vs-Grade 4 |
5.696800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.172800E-01 |
| Normal-vs-ccB subtype |
2.992200E-01 |
| ccA subtype-vs-ccB subtype |
2.106400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.268000E-01 |
| Normal-vs-N1 |
1.648360E-01 |
| N0-vs-N1 |
3.519400E-01 |
|
|
